Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Affibody Molecules in Biotechnological and Medical Applications
KTH, School of Biotechnology (BIO), Protein Technology.ORCID iD: 0000-0002-9282-0174
KTH, School of Biotechnology (BIO), Protein Technology.ORCID iD: 0000-0002-5391-600X
KTH, School of Biotechnology (BIO), Protein Technology.ORCID iD: 0000-0002-0695-5188
Show others and affiliations
2017 (English)In: Trends in Biotechnology, ISSN 0167-7799, E-ISSN 1879-3096, Vol. 35, no 8, p. 691-712Article, review/survey (Refereed) Published
Abstract [en]

Affibody molecules are small (6.5-kDa) affinity proteins based on a three-helix bundle domain framework. Since their introduction 20 years ago as an alternative to antibodies for biotechnological applications, the first therapeutic affibody molecules have now entered clinical development and more than 400 studies have been published in which affibody molecules have been developed and used in a variety of contexts. In this review, we focus primarily on efforts over the past 5 years to explore the potential of affibody molecules for medical applications in oncology, neurodegenerative, and inflammation disorders, including molecular imaging, receptor signal blocking, and delivery of toxic payloads. In addition, we describe recent examples of biotechnological applications, in which affibody molecules have been exploited as modular affinity fusion partners.

Place, publisher, year, edition, pages
Elsevier, 2017. Vol. 35, no 8, p. 691-712
National Category
Biological Sciences
Identifiers
URN: urn:nbn:se:kth:diva-211597DOI: 10.1016/j.tibtech.2017.04.007ISI: 000405847200005OAI: oai:DiVA.org:kth-211597DiVA, id: diva2:1131680
Note

QC 20170815

Available from: 2017-08-15 Created: 2017-08-15 Last updated: 2017-08-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records BETA

Ståhl, StefanGräslund, TorbjörnEriksson Karlström, AmelieNygren, Per-ÅkeLöfblom, John

Search in DiVA

By author/editor
Ståhl, StefanGräslund, TorbjörnEriksson Karlström, AmelieNygren, Per-ÅkeLöfblom, John
By organisation
Protein Technology
In the same journal
Trends in Biotechnology
Biological Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 193 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf